About:
VRise Therapeutics is a precision oncology company developing small molecule drugs to target cancer growth, proliferation, and differentiation pathways. Their focus on biomarker-driven targets allows for the development of personalized medicines with enhanced treatment efficacy and minimal side effects. Using global resources, they have been able to validate some of their promising therapeutics for colorectal, lung, and pancreatic cancers. VRise Therapeutics is committed to pioneering and accelerating innovative solutions in oncology, driven by a dedication to improving patient outcomes and transforming cancer care through targeted therapies.